Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire. 1986

J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote

A prevalence study of antibody to human immunodeficiency virus (HIV) was conducted in Kinshasa, Zaïre, among 258 children 2-24 months old who were in hospital, 191 children 1-20 months old who were attending a well-child clinic, and their mothers. 8% of the mothers of both groups of children were seropositive. Among children under 9 months old, 12 of 102 (12%) hospital inpatients and 11 of 136 (8%) clinic attenders were seropositive, while in the 9-24-month age group 20 of 156 (13%) hospital children and only 1 of 55 (2%) clinic children were seropositive (Fisher's exact test, p = 0.01). 61% of the seropositive children had seropositive mothers, indicating a high rate of vertical transmission. Factors associated with seropositivity among hospital children with seronegative mothers included male sex, increased lifetime number of medical injections, and previous blood transfusion or hospital admission. Among children who had not previously been transfused or admitted to hospital the seropositives had received more medical injections than the seronegatives (median 34.5 versus 14.5; Wilcoxon rank sum test, p = 0.006). HIV infection accounted for or complicated a substantial proportion of hospital paediatric admissions. Public health measures are urgently required to prevent parenteral and vertical transmission of HIV to infants and young children in Kinshasa.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
December 1990, AIDS (London, England),
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
July 1993, AIDS research and human retroviruses,
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
March 1989, World Health Organization AIDS technical bulletin,
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
June 1988, Annales de la Societe belge de medecine tropicale,
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
May 1991, AIDS (London, England),
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
June 1993, The Journal of infectious diseases,
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
August 2013, Indian journal of pediatrics,
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
September 1992, Archives of internal medicine,
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
February 1995, The Journal of infectious diseases,
J M Mann, and H Francis, and F Davachi, and P Baudoux, and T C Quinn, and N Nzilambi, and N Bosenge, and R L Colebunders, and P Piot, and N Kabote
January 2020, American journal of otolaryngology,
Copied contents to your clipboard!